1 Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2016;132:4–10.
2 Wik HS, Jacobsen AF, Sandvik L, Sandset PM. Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. Journal of thrombosis and haemostasis: JTH. 2012;10:840–7.
3 Gynaecologists RCoOa. Reducing the Risk of Thrombosis and Embolism During Pregnancy and the Puerperium. Green-top Guideline 2015.
4 Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e691S–736S.
5 Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36:527–53.
6 McLintock C, Brighton T, Chunilal S, et al. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period. Aust N Z J Obstet Gynaecol. 2012;52:14–22.
7 McLintock C, Brighton T, Chunilal S, et al. Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol. 2012;52:3–13.
8 James A, Committee on Practice B-O. Practice bulletin no. 123: thromboembolism in pregnancy. Obstetrics and gynecology. 2011;118:718–29.
9 Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:3317–59.
10 Cantrell LA, Garcia C, Maitland HS. Thrombosis and Thromboprophylaxis in Gynecology Surgery. Clin Obstet Gynecol. 2018;61:269–77.
11 Sultan AA, West J, Grainge MJ, et al. Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study. BMJ. 2016;355:i6253.
12 Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. The New England journal of medicine. 2004;351:2581–9.
13 Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014:CD001689.
14 de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014:CD010813.
15 Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:f5298.
16 (SGGG) SGfGuG. Expertenbrief No. 72 (05.03.2021, ersetzt Nr. 35): Thromboembolierisiko unter hormonaler Kontrazeption. Bern: SGGG; 2021. https://www.sggg.ch/fileadmin/user_upload/Dokumente/1_Ueber_uns/1_Verband/2_Arbeitsgemeinschaften/72_Thromboembolierisiko_unter_hormonaler_Kontrazeption_ersetzt_No_35.pdf
17 Sennstrom M, Rova K, Hellgren M, et al. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand. 2017;96:1045–52.
18 Henriksson P, Westerlund E, Wallen H, Brandt L, Hovatta O, Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:e8632.
19 Hansen AT, Kesmodel US, Juul S, Hvas AM. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod. 2012;27:1499–503.
20 Hansen AT, Kesmodel US, Juul S, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29:611–7.
21 Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41:92–128.
22 Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood. 2011;118:5394–400.
23 (SGGG) SGfGuG. Expertenbrief No. 57: Risikospezifizierung Präeklampsie im 1. Trimester. Bern: SGGG 2019.
https://www.sggg.ch/fileadmin/user_upload/57_Risikospezifizierung_Praeeklampsie.pdf
24 Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. The New England journal of medicine. 2017;377:613–22.
25 Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218:287–93 e1.
26 Speed V, Roberts LN, Patel JP, Arya R. Venous thromboembolism and women’s health. British journal of haematology. 2018;183:346–63.
27 Cohen H, Arachchillage DR, Middeldorp S, Beyer-Westendorf J, Abdul-Kadir R. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply. Journal of thrombosis and haemostasis: JTH. 2017;15:195–7.